JONATHAN GRIJALVA: Open Payments
NPI 1639777386 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$587 in 26 payments from 12 companies in 2025. Trend: 2023 $111 · 2024 $335 · 2025 $587
Food & beverage: $570Education: $17
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $144 |
| Insmed, Inc. | 4 | $78 |
| Viatris Specialty LLC | 2 | $57 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Baxter Healthcare | 2 | $49 |
| Pulmonx Corporation | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Grifols USA, LLC | 1 | $32 |
| GENZYME CORPORATION | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
Products named: FASENRA, DUPIXENT, Arikayce, YUPELRI, Hillrom - Vest System Model 105 Home Care, CHARTIS CATHETER, AIRSUPRA, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
